1. |
GOLD Executive Committee.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease (Revised 2013)[EB/OL].[2013-12-20].http://www.goldcopd.com.
|
2. |
Fishman A,Martinez F,Naunheim K,et al.A randomized trial comparing lung volume reduction surgery with medical therapy for severe emphysema.N Engl J Med,2003,348:2059-2073.
|
3. |
王辰,主编.呼吸与危重症医学.北京:人民卫生出版社,2012.
|
4. |
Herth FJ,Eberhardt R,Gompelmann D,et al.Radiological and clinical outcomes of using ChartisTM to plan endobronchial valve treatment.Eur Respir J,2013,41:302-308.
|
5. |
Cetti EJ,Moore AJ,Geddes DM.Collateral ventilation.Thorax,2006,61:371-373.
|
6. |
Gierada DS,Yusen BD,Villanuenva IA,et al.Patients selection for lung volume reduction surgery:an objective model based on prior clinical decisions and quantitative CT analysis.Chest,2000,117:991-998.
|
7. |
李楠,邱建星,章巍月,等.支气管内单向活瓣置入肺减容术治疗慢性阻塞性肺疾病1例.中华结核和呼吸杂志,2013,36:124-127.
|
8. |
高平,陈正贤,陈兢兢,等.经支气管镜肺减容术三例.中华医学杂志,2014,94:2227-2228.
|
9. |
Herth FJ,Noppen M,Valipour A,et al.Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort with emphysema.Eur Respir J,2012,39:1334-1342.
|
10. |
Sciurba FC,Ernst A,Herth FJ,et al.A randomised study of endobronchial valves for advanced emphysema.N Engl J Med,2010,363:1233-1244.
|